Home

Centene Corporation Common Stock (CNC)

33.31
-0.47 (-1.39%)
NYSE · Last Trade: Jul 3rd, 6:04 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Securities Fraud Investigation Into Centene Corporation (CNC) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · July 3, 2025
Centene Corporation (CNC) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors concerning the Company’s possible violations of federal securities laws.
CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · July 2, 2025
Centene Corporation (CNC) Climbs to Annual-High Share Price
Shares of Centene Corporation (NYSE:CNC) traded at a new 12-month high today of $85.02. So far today approximately 439,000 shares have been exchanged, as compared to an average 30-day volume of 4.5 million shares.
Via Investor Brand Network · December 23, 2021
Watch for Continued Gains in Shares of Centene Corporation (CNC)
Shares of Centene Corporation (NYSE:CNC) traded today at $83.08, eclipsing its 12-month high. So far today, approximately 1.7 million shares have been exchanged, as compared to an average 30-day volume of 4.4 million shares.
Via Investor Brand Network · December 15, 2021
Securities Fraud Investigation Into Centene Corporation (CNC) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – CNC
The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of the securities laws.
By DJS Law Group · Via Business Wire · July 2, 2025
Duo Health Partners with Arizona Complete Health on Value-Based Care Program to Improve Outcomes for Members with Chronic Kidney Disease and End-Stage Kidney Disease
Duo Health (“Duo”), a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced today it has entered into a strategic partnership with Arizona Complete Health, a company that provides and administers health benefits through individual, Medicaid, Medicare and dual-eligible programs and a Centene Corporation company (NYSE: CNC). This partnership builds on Arizona Complete Health’s existing value-based care nephrology network arrangements and is designed to enhance patient engagement and improve outcomes for Medicare members with CKD and ESKD.
By Duo Health · Via Business Wire · July 16, 2024
Centene Reaffirms Guidance, But Is it Too Late?
Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came
Via MarketBeat · June 4, 2024
Can UnitedHealth Group afford to keep Medicare Advantage plans?
UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop
Via MarketBeat · February 19, 2024
Mega merger in the works? Humana, Cigna explore big deal
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
Via MarketBeat · December 2, 2023
Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks
During the peak of the recent selloff, the healthcare sector outshone, with three stocks showing resilience and impressive upward moves.
Via MarketBeat · October 12, 2023
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Health insurers UnitedHealth, Humana, and Elevance pay steady dividends, offering stability even as the industry faces headwinds regarding Medicaid coverage.
Via MarketBeat · September 28, 2023
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.
Via MarketBeat · June 16, 2023
3 Healthcare Stocks Insiders Are Buying
The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too.
Via MarketBeat · April 13, 2023
Can Molina Healthcare Sustain Its Market-Beating Rally?
While bigger industry peers get more attention, large-cap managed-care provider Molina shows better price strength as well as solid earnings and revenue growth.
Via MarketBeat · October 20, 2022
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
Via MarketBeat · August 9, 2022
Behavioral Health Center of Excellence and Centene Announce Partnership to Advance Quality in Autism Treatment Outcomes
Behavioral Health Center of Excellence (BHCOE), a data-driven healthcare accreditor, today announced a strategic partnership with Centene Corporation (NYSE:CNC) that will research and advance continuous improvement in Applied Behavioral Analysis (ABA) treatment delivery and support access to quality services for people on the autism spectrum and related developmental disabilities.